Latest Breaking News On - அலெக்ஸாண்ட்ரே மெனிசஸ் - Page 1 : vimarsana.com

Despite recent intensification of control measures, Plasmodium vivax poses a major challenge for malaria elimination efforts. Liver-stage hypnozoite parasites that cause relapsing infections can be cleared with primaquine; however, poor treatment adherence undermines drug effectiveness. Tafenoquine, a new single-dose treatment, offers an alternative option for preventing relapses and reducing transmission. In 2018, over 237,000 cases of malaria were reported to the Brazilian health system, of which 91.5% were due to P. Methods and findings We evaluated the impact of introducing tafenoquine into case management practices on population-level transmission dynamics using a mathematical model of P. P. vivax endemic settings in Brazil in 2018, informed by nationwide malaria case reporting data. Parameters for treatment pathways with chloroquine, primaquine, and tafenoquine with glucose-6-phosphate dehydrogenase deficiency (G6PDd) testing were informed by clinical trial data an

United statesGrewal daumerieAlexandre menezesMelanie larsonGonzalo domingoElodie jambertBrazilian institute of geographyBrazilian instituteSouth americaPenny grewal daumerieParasitic diseasesஒன்றுபட்டது மாநிலங்களில்அலெக்ஸாண்ட்ரே மெனிசஸ்மெலனி லார்சன்கோன்சலோ டொமிஂகொபிரேசிலியன் நிறுவனம் ஆஃப் நிலவியல்